期刊文献+

不同高雄激素血症表型多囊卵巢综合征代谢特征分析 被引量:10

下载PDF
导出
摘要 目的探讨不同高雄激素血症表型多囊卵巢综合征代谢特征。方法回顾性分析我科门诊收治的238名多囊卵巢综合征患者,按患者高雄激素血症的特点分为4组:A组-单纯高雄烯二酮(AND),B组-单纯高睾酮(T),C组-高雄烯二酮伴高睾酮,D组-正常的雄烯二酮和正常睾酮。同时选取85例正常妇女为对照组(E组)。比较高雄激素血症不同表型间体重指数、年龄、内分泌和代谢差异。结果有高雄烯二酮水平(A组和C组)的多囊卵巢综合征的妇女与正常妇女相比BMI、腰臀比、甘油三酯和空腹胰岛素有差异(P<0.05)。结论在多囊卵巢综合征中,有高雄烯二酮的妇女更容易发生肥胖、脂代谢异常和胰岛素抵抗。
出处 《江西医药》 CAS 2016年第5期437-439,共3页 Jiangxi Medical Journal
基金 江西省九江市科技计划项目 项目编号:201402010
  • 相关文献

参考文献8

  • 1Farah L,Lasenby AJ,8oots LR,et al. Prevalence of polycystie ovary syndrome in women seeking treatment from community electrologists. Alabama professional electrology association study group[J]. J Reprod Med, 1999,44:870-874.
  • 2Diamanti-Kandarakis E,Kouli CR,Bergiele AT,et al. A survey of the polycystic ovary syndromein the Greek is!and of Lesbos hormonal and metabolic profile[J]. J Clin Endocrinol Metab, 1999, 84:4006-4011.
  • 3Homburg R. Androgen circle of polycystieovary syndrome [J]. Hum Reprod, 2009,24(7) : 1548-55.
  • 4Li R,Zhang Q,Yang D,et al. Prevalence of polyeystie ovary syndrome in women in China:a large communty-based study[J]. Hum Reprod, 2013,28(9) : 2562-9.
  • 5March WA,Moore VM ,Willson KJ,et 1. The prevalence of polye- ystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria[J]. Hum Repred, 2010,25(2): 544-51.
  • 6The Rotterdam ESHRE/ASRM sponsored PCOS Consensus Worksho-GroupRevised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome(PCOS) [J]. Hum Rep Rod,2004,19(1):4i-47.
  • 7乔杰.多囊卵巢综合征与代谢综合征的关系[J].中国实用妇科与产科杂志,2007,23(9):686-688. 被引量:9
  • 8于传鑫.实用妇科内分泌学[M].第.2版.上海:後旦大学出版社.2006.142.

二级参考文献12

  • 1姚军,钱荣立.多囊卵巢综合征与代谢综合征[J].中华糖尿病杂志(1006-6187),2005,13(2):151-151. 被引量:4
  • 2Reaven GM.Role of insulin resistance in human disease (syndrome Ⅹ):an expanded definition[J].Ann Rev Med,1993,44:121-131.
  • 3Balkau B,Charles MA.Comments on the provisional report from the WHO consultation:European group for the study of insulin resistance[J].Diabetic Med,1999,16:442-443.
  • 4Third Report of the National Cholesterol Education Program (NECP) Expert Panel on Detection,Envaluation,and Treatment of High Blood Cholesterol in Adults (adult treatment Panel Ⅲ).Final report[J].Circulation,2002,106:3143-3421.
  • 5Apridonidze T,Essah PA,Iuorno MJ,et al.Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2005,90:1929-1935.
  • 6Dokras A,Bochner M,Hollinrake E,et al.Screening women with polycystic ovarian syndrome for metabolic syndrome[J].Obstet Gynecol,2005,106:131-137.
  • 7Faloia E,Canibus P,Gatti C,et al.Body composition,fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome[J].J Endocrinol Invest,2004,27:424-429.
  • 8Coviello AD,Legro RS,Dunaif A.Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance[J].J Clin Endocrinol Metab,2006,91:393-395.
  • 9Wild S,Pierpoint T,McKeigue P,et al.Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up:a retrospective cohort study[J].Clin Endocrinol,2000,52:595-600.
  • 10Legro RS,Kunselman AR,Dodson WC,et al.Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome:a prospective,controlled study in 254 affected women[J].J Clin Endoorinol Metab,1999,84:165-169.

共引文献8

同被引文献145

引证文献10

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部